Information is power and with the need to prove to patients, clinicians and payers the positive impact of their drugs on the patient’s health the pharmaceutical industry is successfully using patient reported outcomes (PROs) to gain that power. PRO data is tailored made for marketing a product, to educate patients on the benefits of the drug, to create well defined communications and educational materials.
Used in international clinical trials, adapted for use in nearly 30 different languages and completed by more than 10,000 patients, the Diabetes Health Profile (DHP) with established psychometric and operational performance, including reliability, validity and patient acceptability as well as provisional evidence on cost utility scores and MIDs, provides scientifically valid information that can help prove the effectiveness of your product in clinical trials and beyond.
Cognitively simple, with high completion rates and taking only a few minutes to complete with data capture via paper/pencil, hand held device, tablet, IVR and internet the DHP can support you to:
- Identify unmet need
- Demonstrate drug efficacy
- Build an economic case for formulary inclusion
- Differentiate products and gain market share
- Raise consumer and clinician awareness
Key characteristics of the DHP-1 and DHP-18
Appraisal of psychometric and operational performance criteria
Keith Meadows - Founder
Diabetes Health Profile Scores are Associated with Diabetes-related Complication...
Findings to be presented at the ISPOR 16th Annual European C...More...
Consulting & Training
Research training from £215pp
Our focus is to provide high quality diabetes-related research, consultancy and training please click here...